Gene targeting and subsequent site-specific transgenesis at the β-actin (ACTB) locus in common marmoset embryonic stem cells

Stem Cells and Development

Volumn 20, Issue 9, 2011, Pages 1587-1599

  Shiozawa, Seiji ^a,b,c   Kawai, Kenji ^b   Okada, Yohei ^a   Tomioka, Ikuo ^b   Maeda, Takuji ^a,b   Kanda, Akifumi ^c   Shinohara, Haruka ^b   Suemizu, Hiroshi ^b   James Okano, Hirotaka ^a   Sotomaru, Yusuke ^c   Sasaki, Erika ^b   Okano, Hideyuki ^a  

^a KEIO UNIVERSITY   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CRE RECOMBINASE; ENHANCED GREEN FLUORESCENT PROTEIN; GANCICLOVIR; RED FLUORESCENT PROTEIN; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALLITRICHINAE; CELL FATE; CELL GROWTH; CONTROLLED STUDY; CRE RECOMBINASE MEDIATED CASSETTE EXCHANGE; DNA MODIFICATION; EMBRYO; EMBRYONIC STEM CELL; GENE CASSETTE; GENE INSERTION; GENE LOCUS; GENE TARGETING; HERPES SIMPLEX VIRUS; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STEM CELL TRANSPLANTATION; TRANSGENE; TRANSGENICS; TUMOR CELL;

ACTINS; ALPHA-FETOPROTEINS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CALLITHRIX; CELL DIFFERENTIATION; CELLS, CULTURED; CLONING, MOLECULAR; COCULTURE TECHNIQUES; EMBRYONIC STEM CELLS; GENE TARGETING; GENE TRANSFER TECHNIQUES; GENETIC LOCI; GREEN FLUORESCENT PROTEINS; KARYOTYPE; MICE; MICE, INBRED NOD; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; NEURAL CELL ADHESION MOLECULES; RECOMBINANT FUSION PROTEINS; TERATOMA; VIMENTIN;

ANIMALIA; CALLITHRIX JACCHUS; MUS; PRIMATES; SIMPLEXVIRUS;

EID: 80052319264     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0351     Document Type: Article

References (61)

1. Evans MJ and MH Kaufman. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156.
2. Martin GR. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78:7634-7638.
3. Capecchi MR. (2005). Gene targeting in mice: Functional analysis of the mammalian genome for the twenty-first century. Nat Rev Genet 6:507-512.
4. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
5. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
6. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, R Stewart, II Slukvin and JA Thomson. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
7. Liew CG, JS Draper, J Walsh, H Moore and PW Andrews. (2007). Transient and stable transgene expression in human embryonic stem cells. Stem Cells 25:1521-1528.
8. Xia X, Y Zhang, CR Zieth and SC Zhang. (2007). Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner. Stem Cells Dev 16:167-176.
9. Hibino H, K Tani, K Ikebuchi, MS Wu, H Sugiyama, Y Nakazaki, T Tanabe, S Takahashi, A Tojo, S Suzuki, Y Tanioka, Y Sugimoto, T Nakahata and S Asano. (1999). The common marmoset as a target preclinical primate model for cytokine and gene therapy studies. Blood 93:2839-2848.
10. Mansfield K. (2003). Marmoset models commonly used in biomedical research. Comp Med 53:383-392.
11. Sasaki E, H Suemizu, A Shimada, K Hanazawa, R Oiwa, M Kamioka, I Tomioka, Y Sotomaru, R Hirakawa, T Eto, S Shiozawa, T Maeda, M Ito, R Ito, C Kito, C Yagihashi, K Kawai, H Miyoshi, Y Tanioka, N Tamaoki, S Habu, H Okano and T Nomura. (2009). Generation of transgenic non-human primates with germline transmission. Nature 459:523-527.
12. Sasaki E, K Hanazawa, R Kurita, A Akatsuka, T Yoshizaki, H Ishii, Y Tanioka, Y Ohnishi, H Suemizu, A Sugawara, N Tamaoki, K Izawa, Y Nakazaki, H Hamada, H Suemori, S Asano, N Nakatsuji, H Okano and K Tani. (2005). Establishment of novel embryonic stem cell lines derived from the common marmoset (Callithrix jacchus). Stem Cells 23:1304-1313.
13. Muller T, G Fleischmann, K Eildermann, K Matz-Rensing, PA Horn, E Sasaki and R Behr. (2009). A novel embryonic stem cell line derived from the common marmoset monkey (Callithrix jacchus) exhibiting germ cell-like characteristics. Hum Reprod 24:1359-1372.
14. Oumard A, J Qiao, T Jostock, J Li and J Bode. (2006). Recommended method for chromosome exploitation: RMCE-based cassette-exchange systems in animal cell biotechnology. Cytotechnology 50:93-108.
15. Bouhassira EE, K Westerman and P Leboulch. (1997). Transcriptional behavior of LCR enhancer elements integrated at the same chromosomal locus by recombinasemediated cassette exchange. Blood 90:3332-3344.
16. Feng YQ, J Seibler, R Alami, A Eisen, KA Westerman, P Leboulch, S Fiering and EE Bouhassira. (1999). Site-specific chromosomal integration in mammalian cells: Highly efficient CRE recombinase-mediated cassette exchange. J Mol Biol 292:779-785.
17. Araki K, M Araki and K Yamamura. (2002). Site-directed integration of the cre gene mediated by Cre recombinase using a combination of mutant lox sites. Nucleic Acids Res 30:e103.
18. Zambrowicz BP, A Imamoto, S Fiering, LA Herzenberg, WG Kerr and P Soriano. (1997). Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci U S A 94:3789-3794.
19. Shmerling D, CP Danzer, X Mao, J Boisclair, M Haffner, M Lemaistre, V Schuler, E Kaeslin, R Korn, K Burki, B Ledermann, B Kinzel and M Muller. (2005). Strong and ubiquitous expression of transgenes targeted into the betaactin locus by Cre/lox cassette replacement. Genesis 42:229-235.
20. Garcia-Otin AL and F Guillou. (2006). Mammalian genome targeting using site-specific recombinases. Front Biosci 11:1108-1136.
21. Di Domenico AI, I Christodoulou, SC Pells, J McWhir and AJ Thomson. (2008). Sequential genetic modification of the hprt locus in human ESCs combining gene targeting and recombinase- mediated cassette exchange. Cloning Stem Cells 10:217-230.
22. Liu Y, B Thyagarajan, U Lakshmipathy, H Xue, P Lieu, A Fontes, CC MacArthur, K Scheyhing, MS Rao and JD Chesnut. (2009). Generation of platform human embryonic stem cell lines that allow efficient targeting at a predetermined genomic location. Stem Cells Dev 18:1459-1472.
23. Du ZW, BY Hu, M Ayala, B Sauer and SC Zhang. (2009). Cre recombination-mediated cassette exchange for building versatile transgenic human embryonic stem cells lines. Stem Cells 27:1032-1041.
24. Sakurai K, M Shimoji, CG Tahimic, K Aiba, E Kawase, K Hasegawa, Y Amagai, H Suemori and N Nakatsuji. (2010). Efficient integration of transgenes into a defined locus in human embryonic stem cells. Nucleic Acids Res 38:e96.
25. Kolb AF. (2001). Selection-marker-free modification of the murine beta-casein gene using a lox2272 [correction of lox2722] site. Anal Biochem 290:260-271.
26. Kondo S, A Okuda, H Sato, N Tachikawa, M Terashima, Y Kanegae and I Saito. (2003). Simultaneous on/off regulation of transgenes located on a mammalian chromosome with Cre-expressing adenovirus and a mutant loxP. Nucleic Acids Res 31:e76.
27. Masui S, D Shimosato, Y Toyooka, R Yagi, K Takahashi and H Niwa. (2005). An efficient system to establish multiple embryonic stem cell lines carrying an inducible expression unit. Nucleic Acids Res 33:e43.
28. Niculescu-Duvaz I and CJ Springer. (2005). Introduction to the background, principles, and state of the art in suicide gene therapy. Mol Biotechnol 30:71-88.
29. Fang J, JJ Qian, S Yi, TC Harding, GH Tu, M VanRoey and K Jooss. (2005). Stable antibody expression at therapeutic levels using the 2A peptide. Nat Biotechnol 23:584-590.
30. Sugawara A, K Goto, Y Sotomaru, T Sofuni and T Ito. (2006). Current status of chromosomal abnormalities in mouse embryonic stem cell lines used in Japan. Comp Med 56: 31-34.
31. Ito M, H Hiramatsu, K Kobayashi, K Suzue, M Kawahata, K Hioki, Y Ueyama, Y Koyanagi, K Sugamura, K Tsuji, T Heike and T Nakahata. (2002). NOD/SCID/gamma(c)(null) mouse: An excellent recipient mouse model for engraftment of human cells. Blood 100:3175-3182.
32. Campbell RE, O Tour, AE Palmer, PA Steinbach, GS Baird, DA Zacharias and RY Tsien. (2002). A monomeric red fluorescent protein. Proc Natl Acad Sci U S A 99:7877-7882.
33. Corbett TH, DP Griswold Jr., BJ Roberts, JC Peckham and FM Schabel Jr. (1977). Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas. Cancer 40:2660-2680.
34. Ng SY, P Gunning, R Eddy, P Ponte, J Leavitt, T Shows and L Kedes. (1985). Evolution of the functional human betaactin gene and its multi-pseudogene family: Conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol Cell Biol 5:2720-2732.
35. Tesar PJ, JG Chenoweth, FA Brook, TJ Davies, EP Evans, DL Mack, RL Gardner and RD McKay. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448:196-199.
36. Brons IG, LE Smithers, MW Trotter, P Rugg-Gunn, B Sun, SM Chuva de Sousa Lopes, SK Howlett, A Clarkson, L Ahrlund-Richter, RA Pedersen and L Vallier. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448:191-195.
37. Hanna J, AW Cheng, K Saha, J Kim, CJ Lengner, F Soldner, JP Cassady, J Muffat, BW Carey and R Jaenisch. (2010). Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A 107:9222-9227.
38. Ying QL, J Wray, J Nichols, L Batlle-Morera, B Doble, J Woodgett, P Cohen and A Smith. (2008). The ground state of embryonic stem cell self-renewal. Nature 453:519-523.
39. Buehr M, S Meek, K Blair, J Yang, J Ure, J Silva, R McLay, J Hall, QL Ying and A Smith. (2008). Capture of authentic embryonic stem cells from rat blastocysts. Cell 135:1287-1298.
40. Li P, C Tong, R Mehrian-Shai, L Jia, N Wu, Y Yan, RE Maxson, EN Schulze, H Song, CL Hsieh, MF Pera and QL Ying. (2008). Germline competent embryonic stem cells derived from rat blastocysts. Cell 135:1299-1310.
41. Feng YQ, MC Lorincz, S Fiering, JM Greally and EE Bouhassira. (2001). Position effects are influenced by the orientation of a transgene with respect to flanking chromatin. Mol Cell Biol 21:298-309.
42. Irion S, H Luche, P Gadue, HJ Fehling, M Kennedy and G Keller. (2007). Identification and targeting of the ROSA26 locus in human embryonic stem cells. Nat Biotechnol 25:1477-1482.
43. Yanez RJ and AC Porter. (1999). Influence of DNA delivery method on gene targeting frequencies in human cells. Somat Cell Mol Genet 25:27-31.
44. Zwaka TP and JA Thomson. (2003). Homologous recombination in human embryonic stem cells. Nat Biotechnol 21:319-321.
45. Suzuki K, K Mitsui, E Aizawa, K Hasegawa, E Kawase, T Yamagishi, Y Shimizu, H Suemori, N Nakatsuji and K Mitani. (2008). Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helperdependent adenoviral vectors. Proc Natl Acad Sci U S A 105:13781-13786.
46. Mitani K, FL Graham, CT Caskey and S Kochanek. (1995). Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc Natl Acad Sci U S A 92:3854-3858.
47. Ohbayashi F, MA Balamotis, A Kishimoto, E Aizawa, A Diaz, P Hasty, FL Graham, CT Caskey and K Mitani. (2005). Correction of chromosomal mutation and random integration in embryonic stem cells with helper-dependent adenoviral vectors. Proc Natl Acad Sci U S A 102:13628-13633.
48. Palmer DJ and P Ng. (2005). Helper-dependent adenoviral vectors for gene therapy. Hum Gene Ther 16:1-16.
49. Knoepfler PS. (2009). Deconstructing stem cell tumorigenicity: A roadmap to safe regenerative medicine. Stem Cells 27:1050-1056.
50. Carpenter MK, J Frey-Vasconcells and MS Rao. (2009). Developing safe therapies from human pluripotent stem cells. Nat Biotechnol 27:606-613.
51. Draper JS, K Smith, P Gokhale, HD Moore, E Maltby, J Johnson, L Meisner, TP Zwaka, JA Thomson and PW Andrews. (2004). Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 22:53-54.
52. Maitra A, DE Arking, N Shivapurkar, M Ikeda, V Stastny, K Kassauei, G Sui, DJ Cutler, Y Liu, SN Brimble, K Noaksson, J Hyllner, TC Schulz, X Zeng, WJ Freed, J Crook, S Abraham, A Colman, P Sartipy, S Matsui, M Carpenter, AF Gazdar, M Rao and A Chakravarti. (2005). Genomic alterations in cultured human embryonic stem cells. Nat Genet 37:1099-1103.
53. Lefort N, M Feyeux, C Bas, O Feraud, A Bennaceur-Griscelli, G Tachdjian, M Peschanski and AL Perrier. (2008). Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nat Biotechnol 26:1364-1366.
54. Spits C, I Mateizel, M Geens, A Mertzanidou, C Staessen, Y Vandeskelde, J Van der Elst, I Liebaers and K Sermon. (2008). Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol 26:1361-1363.
55. Schuldiner M, J Itskovitz-Eldor and N Benvenisty. (2003). Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells 21:257-265.
56. Kiuru M, JL Boyer, TP O'Connor and RG Crystal. (2009). Genetic control of wayward pluripotent stem cells and their progeny after transplantation. Cell Stem Cell 4:289-300.
57. Culver KW, Z Ram, S Wallbridge, H Ishii, EH Oldfield and RM Blaese. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:1550-1552.
58. Caruso M, Y Panis, S Gagandeep, D Houssin, JL Salzmann and D Klatzmann. (1993). Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci U S A 90:7024-7028.
59. Gao Ding C, W An and J Dai. (1999). Retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for hepatocellular carcinoma. Cell Res 9:225-235.
60. Pulkkanen KJ, JJ Parkkinen, JM Laukkanen, MI Kettunen, K Tyynela, RA Kauppinen, MY Ala-Opas and S Yla-Herttuala. (2001). HSV-tk gene therapy for human renal cell carcinoma in nude mice. Cancer Gene Ther 8:529-536.
61. Di Ianni M, A Terenzi, F Falzetti, A Bartoli, S Di Florio, R Benedetti, G Venditti, D Alfonsi, M De Ioanni, B Falini and A Tabilio. (2002). Homing and survival of thymidine kinasetransduced human T cells in NOD/SCID mice. Cancer Gene Ther 9:756-761.